The FDA said children with attention deficit hyperactivity disorder should continue taking medications for their condition because there is no sufficient evidence that the drugs cause sudden death. The warning follows a study partly funded by the agency that cites 10 cases of sudden death in the patient group taking stimulants.

Related Summaries